|
⚲
|
| Keyboard |
| Mark Weeks | |
|---|---|
| Firm | |
| Address | 1440 Obrien Drive Suite B Menlo Park, CA 94025 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Octave Bioscience Inc | 021-385495 | Executive Officer | 32.0 M of 32.0 M |
||
| Auxogyn Inc | 021-236224 | Executive Officer | 34.3 M of 41.0 M |
||
| Carbylan Biosurgery Inc | 021-189403 | Executive Officer | 6.0 M of 13.2 M |
||
| Cardiodx Inc | 021-183494 | Executive Officer | 30.5 M of 58.0 M |
||
| Cardiodx Inc | 021-156088 | Executive Officer | 57.5 M of 78.3 M |
||
| Cardiodx Inc | 021-142039 | Executive Officer | 34.6 M of 44.5 M |
||
| Acelrx Pharmaceuticals Inc | 021-115115 | Executive Officer | 14.8 M of 30.0 M |
||
| Direct Flow Medical Inc | 021-67186 | Executive Officer | 40.3 M of 42.5 M |
||